Treatment of Inflammatory Bowel Disease With Vedolizumab for Patients With Coexisting Primary Sclerosing Cholangitis: Report of a Nested Case-Control Study

被引:3
|
作者
Damas, Oriana M.
Estes, Derek
Polanco, Nathalie A. Pena
Czul, Frank
Palacio, Ana M.
Abreu, Maria T.
Levy, Cynthia
机构
关键词
D O I
10.1016/S0016-5085(16)33623-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1580
引用
收藏
页码:S1074 / S1074
页数:1
相关论文
共 50 条
  • [1] Effectiveness of Vedolizumab in Patients With Inflammatory Bowel Disease and Concomitant Primary Sclerosing Cholangitis
    Santiago, Priscila
    Robateau, Anthony
    Lopdrup, Rachel G.
    Neto, Manuel B. Braga
    Raffals, Laura
    Eaton, John
    Ramos, Guilherme
    Loftus, Edward V.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S688 - S689
  • [2] INTERNATIONAL EXPERIENCE OF VEDOLIZUMAB IN PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE
    Williamson, Kate D.
    Lytvyak, Ellina
    de Krijger, Manon
    Trivedi, Palak
    Estes, Derek
    Yu, Le
    Pratt, Daniel
    de Vries, Annemarie C.
    Daretti, Luigi
    Liu, Chung Heng
    Bowlus, Christopher L.
    Marschall, Hanns-Ulrich
    Montano-Loza, Aldo J.
    Chapman, Roger W.
    Van der Woude, Christien Janneke
    Marzioni, Marco
    Keshav, Satish
    Ponsioen, Cyriel
    Hirschfield, Gideon
    Levy, Cynthia
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S1097 - S1097
  • [3] Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
    Lynch, Kate D.
    Chapman, Roger W.
    Keshav, Satish
    Montano-Loza, Aldo J.
    Mason, Andrew L.
    Kremer, Andreas E.
    Vetter, Marcel
    de Krijger, Manon
    Ponsioen, Cyriel Y.
    Trivedi, Palak
    Hirschfield, Gideon
    Schramm, Christoph
    Liu, Chung Heng
    Bowlus, Christopher L.
    Estes, Derek J.
    Pratt, Daniel
    Hedin, Charlotte
    Bergquist, Annika
    de Vries, Annemarie C.
    van der Woude, C. Janneke
    Yu, Lei
    Assis, David N.
    Boyer, James
    Ytting, Henriette
    Hallibasic, Emina
    Trauner, Michael
    Marschall, Hanns-Ulrich
    Daretti, Luigi M.
    Marzioni, Marco
    Yimam, Kidist K.
    Perin, Nicola
    Floreani, Annarosa
    Beretta-Piccoli, Benedetta Terziroli
    Rogers, Jennifer K.
    Levy, Cynthia
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (01) : 179 - +
  • [4] CLINICAL AND TRANSLATIONAL OUTCOMES IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE RECEIVING VEDOLIZUMAB
    Williamson, Kate D.
    Slevin, Stephanie
    Willberg, Christian
    Chapman, Roger W.
    Klenerman, Paul
    Keshav, Satish
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S1186 - S1187
  • [5] Clinical and translational outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease receiving vedolizumab
    Williamson, K. D.
    Slevin, S.
    Willberg, C.
    Chapman, R.
    Klenerman, P.
    Keshav, S.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S544 - S545
  • [6] Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study
    Caron, Benedicte
    Peyrin-Biroulet, Laurent
    Pariente, Benjamin
    Bouhnik, Yoram
    Seksik, Philippe
    Bouguen, Guillaume
    Caillo, Ludovic
    Laharie, David
    Carbonnel, Franck
    Altwegg, Romain
    Reenaers, Catherine
    Serrero, Melanie
    Trang-Poisson, Caroline
    Nancey, Stephane
    Filippi, Jerome
    Abitbol, Vered
    Savoye, Guillaume
    Vuitton, Lucine
    Viennot, Stephanie
    Fumery, Mathurin
    Reymond, Maud
    Bronowicki, Jean-Pierre
    Reimund, Jean-Marie
    Amiot, Aurelien
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 (10): : 1239 - 1247
  • [7] Prognosis of Primary Sclerosing Cholangitis in Israel is Independent of Coexisting Inflammatory Bowel Disease
    Yanai, Henit
    Matalon, Shay
    Rosenblatt, Amir
    Awadie, Halim
    Berdichevski, Tania
    Snir, Yifat
    Kopylov, Uri
    Katz, Lior
    Stein, Assaf
    Mlynarsky, Liat
    Tulchinsky, Hagit
    Konikoff, Fred Meir
    Ben Horin, Shomron
    Braun, Marius
    Ben-Ari, Ziv
    Chowers, Yehuda
    Baruch, Yaacov
    Shibolet, Oren
    Dotan, Iris
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 (02): : 177 - 184
  • [8] Letter: vedolizumab for the management of inflammatory bowel disease in patients after liver transplantation for primary sclerosing cholangitis
    Hartery, K.
    O'Reilly, S.
    Houlihan, D.
    Doherty, G.
    Mulcahy, H.
    Cullen, G.
    Sheridan, J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (02) : 376 - 378
  • [9] Vedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAID
    Caron, B.
    Peyrin-Biroulet, L.
    Nachury, M.
    Bouhnik, Y.
    Seksik, P.
    Bouguen, G.
    Caillo, L.
    Laharie, D.
    Carbonnel, F.
    Altwegg, R.
    Reenaers, C.
    Serrero, M.
    Boureille, A.
    Nancey, S.
    Filippi, J.
    Abitbol, V.
    Savoye, G.
    Vuitton, L.
    Viennot, S.
    Fumery, M.
    Reymond, M.
    Bronowicki, J. P.
    Reimund, J. -M.
    Amiot, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S278 - S278
  • [10] Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease
    Kim, You Sun
    Hurley, Edward H.
    Park, Yoojeong
    Ko, Sungjin
    [J]. INTESTINAL RESEARCH, 2023, 21 (04) : 420 - 432